The MEDICREA Group: 2009 Half Year Results
LYON, France–(BUSINESS WIRE)–The MEDICREA Group (Paris: ALMED), listed on Alternext by NYSE – Euronext Paris, a specialist in the design, manufacture and sale of spinal implants, is publishing its 2009 half year results.
HALF YEAR RESULTS IN LINE WITH THE GROUP’S STRATEGY OF STRONG GROWTH
- Sales of €6.1 million at June 30, 2009, up 32%
- Recovery in gross margin
- Bolstered commercial marketing and clinical studies investments, especially in the USA
H1 2009 RESULTS AND SALIENT FACTS
In € millions | H1 2008 | H2 2008 | H1 2009 (1) | |||
Net sales Gross margin in % Operating income EBITDA (2) Pretax income from ordinary activities Income before goodwill amortization Net income |
4,6
68 % (1,7) (0,9) (1,7) (1,2) (1,5) |
4,4
51 % (2,2) (1,6) (2,4) (3,2) (3,4) |
6,1
64 % (1,5) (0,8) (1,7) (1,2) (1,5) |
(1) : Non audited half year accounts – French GAAP
(2) : EBITDA : Earnings before Interests, taxes, depreciation and amortization